Literatur
-
1
Kollef M H, Fraser V J.
Antibiotic resistance in the intensive care unit.
Ann Intern Med.
2001;
134
298-314
-
2
Jones M E, Draghi D C, Thornsberry C, Karlowsky J A, Sahm D F, Wenzel R P.
Emerging resistance among bacterial pathogens in the intensive care unita European and North American Surveillance study (2000 - 2002).
Ann Clin Microbiol Antimicrob.
2004;
3
14
-
3
Meyer E, Schwab F, Jonas D, Ruden H, Gastmeier P, Daschner F D.
Temporal changes in bacterial resistance in German intensive care units, 2001 - 2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
J Hosp Infect.
2005;
60
348-352
-
4
Meyer E, Schwab F, Gastmeier P, Jonas D, Rueden H, Daschner F D.
Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000 - 2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).
Infect Control Hosp Epidemiol.
2006;
27
146-154
-
5
Gardner P, Smith D H, Beer H, Moellering R C.
Recovery of resistance (R) factors from a drug-free community.
Lancet.
1969;
42
774-776
-
6
D’Costa V M, McGrann K M, Hughes D W, Wright G D.
Sampling the antibiotic resistome.
Science.
2006;
311
374-377
-
7
Bonten M J, Mascini E M.
The hidden faces of the epidemiology of antibiotic resistance.
Intensive Care Med.
2003;
29
1-2
-
8
Harbarth S, Romand J, Frei R, Auckenthaler R, Pittet D.
Inter- and intrahospital transmission of methicillin-resistant Staphylococcus aureus.
Schweiz Med Wochenschr.
2007;
127
471-478
-
9
Grundmann H, Barwolff S, Tami A. et al .
How many infections are caused by patient-to-patient transmission in intensive care units?.
Crit Care Med.
2005;
33
946-951
-
10
Cosgrove S E, Kaye K S, Eliopoulous G M, Carmeli Y.
Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species.
Arch Intern Med.
2002;
162
185-190
-
11
Harbarth S, Harris A D, Carmeli Y, Samore M H.
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Clin Infect Dis.
2001;
33
1462-1468
-
12
Courvalin P.
Antimicrobial Drug Resistance: „Prediction Is Very Difficult, Especially about the Future”.
Emerg Infect Dis.
2005;
11
1503-1506
-
13
Lipsitch M, Samore M H.
Antimicrobial use and antimicrobial resistance: a population perspective.
Emerg Infect Dis.
2002;
8
347-54
-
14
Harbarth S, Samore M H.
Antimicrobial resistance determinants and future control.
Emerg Infect Dis.
2005;
11
794-801
-
15
Harbarth S, Cosgrove S, Carmeli Y.
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.
Antimicrob Agents Chemother.
2002;
46
1619-1628
-
16
Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D.
Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
Clin Infect Dis.
2000;
31
1380-1385
-
17
Hawkey P M.
The origins and molecular basis of antibiotic resistance.
BMJ.
1998;
317
657-660
-
18
Deja M, Nachtigall I, Halle E, Kastrup M, Guill M M, Spies C D.
Strategien für die Verordnung von Antibiotika in der Intensivmedizin.
Anästhesiol Intensivmed Notfallmed Schmerzther.
2007;
42
108-115
1 Erstveröffentlichung des Beitrages in: Anästhesiol Intensivmed Notfallmed Schmerzther 2007; 42: 130 - 135
PD Dr. med. Stephan Harbarth
Unité de Prévention et Contrôle de l'Infection des HUG
Hôpital Cantonal
24 rue Micheli-du-Crest
1211 Genf 14
Phone: 022/372-9828
Fax: 022/372-3987
Email: stephan.harbarth@hcuge.ch